Vivani Medical, Inc.
Develops long-term subdermal drug implants for chronic diseases like diabetes & weight management.
VANI | US
Overview
Corporate Details
- ISIN(s):
- US81362J2096 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1350 S. LOOP ROAD, 94502 ALAMEDA
- Website:
- https://vivani.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company developing novel, long-term drug implant solutions for chronic diseases. The company's proprietary NanoPortal™ platform technology enables the creation of miniature, subdermal implants designed to provide steady, continuous drug delivery for six months to a year or longer. This approach aims to solve major treatment challenges, including medication non-adherence and tolerability issues associated with fluctuating drug levels. Vivani's lead pipeline candidates include NPM-139, a semaglutide implant for chronic weight management, and NPM-133, a semaglutide implant for type 2 diabetes. The implants are administered via a simple outpatient procedure, seeking to replace frequent self-injections and improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vivani Medical, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vivani Medical, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vivani Medical, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||